Table 4 Percent (%) distribution of intensity score of marker expression from patients without cancer (tonsil controls), benign squamous epithelium from patients with cancer (benign), high-grade dysplasia (HGD) tissue and squamous cell carcinoma (SCC) tissue

From: Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis

Groups

Markers

Arbitrary scores of staining

intensity

  

% of 0

% of 1+

% of 2+

% of 3+

Tonsil controls

Ki-67

97

0

3

0

N=37

EGFR

81

16

3

0

 

p-Akt

26

57

7

0

 

p-NF-κB

16

68

16

0

Benign N=40

Ki-67

90

0

8

2

 

EGFR

92

8

0

0

 

p-Akt

5

82

5

8

 

p-NF-κB

3

86

8

3

HGD N=26

Ki-67

40

0

12

48

 

EGFR

8

32

40

20

 

p-Akt

0

0

31

69

 

p-NF-κB

0

15

54

31

SCC N=45

Ki-67

4

2

38

56

 

EGFR

4

20

45

31

 

p-Akt

0

0

20

80

 

p-NF-κB

2

23

65

20

  1. EGFR—epidermal growth factor receptors; p-NF-κB—phospho-nuclear factor-kappa B; p-Akt—phospho-Akt.
Back to article page